カテゴリ： MarketLine, アメリカ, 企業調査

BioMarin Pharmaceutical Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4829
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：53
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

BioMarin Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report
Summary

BioMarin Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

BioMarin Pharmaceutical Inc. (BioMarin or ‘the company’), a biotechnology company, develops and commercializes biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates in the US, Europe, Latin America, and other regions of the world. BioMarin is headquartered in San Rafael, California.

Scope

- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
BioMarin Pharmaceutical Inc.: Company Overview
BioMarin Pharmaceutical Inc.: Overview and Key Facts
BioMarin Pharmaceutical Inc.: Overview
BioMarin Pharmaceutical Inc.: Key Facts
BioMarin Pharmaceutical Inc.: Key Employees
BioMarin Pharmaceutical Inc.: Key Employee Biographies
BioMarin Pharmaceutical Inc.: Major Products and Services
BioMarin Pharmaceutical Inc.: Company History
BioMarin Pharmaceutical Inc.: Management Statement
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
BioMarin Pharmaceutical Inc.: Key Competitors
BioMarin Pharmaceutical Inc.: Company Analysis
BioMarin Pharmaceutical Inc.: Business Description
BioMarin Pharmaceutical Inc.: SWOT Analysis
BioMarin Pharmaceutical Inc.: SWOT Overview
BioMarin Pharmaceutical Inc.: Strengths
BioMarin Pharmaceutical Inc.: Weaknesses
BioMarin Pharmaceutical Inc.: Opportunities
BioMarin Pharmaceutical Inc.: Threats
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
BioMarin Pharmaceutical Inc.: Financial Deals Overview
BioMarin Pharmaceutical Inc.: Targets and Partners
BioMarin Pharmaceutical Inc.: Top Deals 2016 – 2020YTD*
BioMarin Pharmaceutical Inc.: Advisors
BioMarin Pharmaceutical Inc.: Top Legal Advisors
BioMarin Pharmaceutical Inc.: Top Financial Advisors
BioMarin Pharmaceutical Inc.: Capital Raising
BioMarin Pharmaceutical Inc.: Partnership
BioMarin Pharmaceutical Inc.: Recent Developments
BioMarin Pharmaceutical Inc.: News and Events Summary
BioMarin Pharmaceutical Inc.: Business Expansion
BioMarin Pharmaceutical Inc.: Corporate Governance
BioMarin Pharmaceutical Inc.: Financial Performance
BioMarin Pharmaceutical Inc.: Market Developments
BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
BioMarin Pharmaceutical Inc.: Research & Development
BioMarin Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: BioMarin Pharmaceutical Inc.: Key Facts
Table 2: BioMarin Pharmaceutical Inc.: Key Employees
Table 3: BioMarin Pharmaceutical Inc.: Company History
Table 4: BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
Table 5: BioMarin Pharmaceutical Inc.: Key Competitors
Table 6: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: BioMarin Pharmaceutical Inc.: Targets and Partners
Table 9: BioMarin Pharmaceutical Inc.: Top Deals 2016 - 2020YTD*
Table 10: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 13: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 14: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 15: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 16: BioMarin Pharmaceutical Inc.: News and Events Summary
Table 17: BioMarin Pharmaceutical Inc.: Business Expansion
Table 18: BioMarin Pharmaceutical Inc.: Corporate Governance
Table 19: BioMarin Pharmaceutical Inc.: Financial Performance
Table 20: BioMarin Pharmaceutical Inc.: Market Developments
Table 21: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
Table 22: BioMarin Pharmaceutical Inc.: Research & Development
Table 23: BioMarin Pharmaceutical Inc.: Strategy and Operations

★海外企業調査レポート[BioMarin Pharmaceutical Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sensus Healthcare Inc (SRTS)：企業の財務・戦略的SWOT分析
    Sensus Healthcare Inc (SRTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Dohler GmbH：企業の戦略・SWOT・財務分析
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sage Therapeutics Inc (SAGE)：製薬・医療：M&Aディール及び事業提携情報
    Summary Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The company ha …
  • Europaeische Reiseversicherung AG：企業の戦略・SWOT・財務情報
    Europaeische Reiseversicherung AG - Strategy, SWOT and Corporate Finance Report Summary Europaeische Reiseversicherung AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • American Bio Medica Corp (ABMC)：企業の製品パイプライン分析2018
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Oxford Biodynamics Plc：企業の製品パイプライン分析2018
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neu …
  • PerkinElmer Inc (PKI)：企業の財務・戦略的SWOT分析
    PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Exmar NV (EXM)：企業の財務・戦略的SWOT分析
    Summary Exmar NV (Exmar) a subsidiary of Compagnie Maritime Belge SA, operates as a shipping and energy supply chain solutions provider. The company's service portfolio includes liquefied natural gas (LNG), offshore, liquid petroleum gas (LPG) and supporting services. Its LNG segment offers floating …
  • Advance Pharmaceutical Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Advance Pharmaceutical Co Ltd (APC), formerly Dang Ling is a healthcare products provider that manufactures and distributes prescription and over the counter pharmaceutical products. The company’s products include vitamins and supplements, cough syrups, skin care, disinfectant liquids, and r …
  • ACWA Power Barka SAOG (APBS)：企業の財務・戦略的SWOT分析
    ACWA Power Barka SAOG (APBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Universal Biosensors Inc (UBI)：企業の財務・戦略的SWOT分析
    Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • China Resources Gas Group Ltd (1193)：石油・ガス：M&Aディール及び事業提携情報
    Summary China Resources Gas Group Ltd (CR Gas), a subsidiary of China Resources (Holdings) Co Ltd, is a gas company that offers distribution of natural gas and petroleum gas. The company provides downstream city gas distribution business including piped natural gas distribution and natural gas filli …
  • Al Hassan Engineering Co (HECI)：企業の財務・戦略的SWOT分析
    Al Hassan Engineering Co (HECI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • KDH Defense Systems, Inc.：企業の戦略・SWOT・財務情報
    KDH Defense Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary KDH Defense Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Chemed Corp (CHE)：企業の財務・戦略的SWOT分析
    Summary Chemed Corp (Chemed) is a diversified company. The company operates through its segments including Vitas and Roto-Rooter. Its Vitas segment provides end-of-life hospice care for heart disease, stroke, multiple sclerosis, lung disease, liver disease, and kidney diseases, among others. Chemed …
  • Standard Chartered Plc：企業のM&A・事業提携・投資動向
    Standard Chartered Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Standard Chartered Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • CiToxLAB Group：製薬・医療：M&Aディール及び事業提携情報
    Summary CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, …
  • Airgain, Inc. (AIRG)：企業の財務・戦略的SWOT分析
    Airgain, Inc. (AIRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Emlin Cosmetics：企業の戦略・SWOT・財務情報
    Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report Summary Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Swedish Orphan Biovitrum AB (SOBI)：企業の財務・戦略的SWOT分析
    Swedish Orphan Biovitrum AB (SOBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆